As of January 2026 Karyopharm Therapeutics has a market cap of โฌ0.11 Billion. This makes Karyopharm Therapeutics the world's 8936th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Jan 7th, 2026 the market cap of Karyopharm Therapeutics was reported to be: